# Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents

> **NCT02337127** · PHASE4 · UNKNOWN · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT02337127
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2015-05
- **Final completion:** 2016-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2015-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02337127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02337127, "Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02337127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*